Substituted quinoline derivatives
The present invention relates to new substituted quinoline compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
Novartis Vaccines and Diagnostics, Inc.
A C A A A A A A A A A C A A A A
A61P C07D A61P A61P A61P A61P A61P A61P A61P A61P A61P C07D A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Ryan N. Kenneth Liana Marie Weibo
Constantine Bair Lagniton Wang